Non-compartmental analysis

Methods in Molecular Biology

Volumn 929, Issue , 2012, Pages 377-389

  Gabrielsson, Johan ^a   Weiner, Daniel ^b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b PHARSIGHT CORPORATION   (United States)

Author keywords

AUC; NCA; Non compartmental; TK; Toxicokinetic

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; INFORMATION PROCESSING; LINEAR SYSTEM; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NON COMPARTMENTAL ANALYSIS; NONLINEAR REGRESSION ANALYSIS; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STEADY STATE; TIME TO MAXIMUM PLASMA CONCENTRATION; TOXICOKINETICS;

EID: 84934436036     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-50-2_16     Document Type: Article

References (16)

1. Gabrielsson J, Weiner D (2006) Pharmacokinetic and pharmacodynamic data analysis: concepts and applications, 4th edn. Swedish Pharmaceutical Press, Stockholm
2. Nakashima E, Benet LZ (1988) General treatment of mean residence time, clearance and volume parameters in linear mamillary models with elimination from any compartment. J Pharmacokinet Biopharm 16:475
3. Nakashima E, Benet LZ (1989) An integrated approach to pharmacokinetic analysis for linear mammillary systems in which input and exit may occur in/from any compartment. J Pharmacokinet Biopharm 17:673
4. Bailer AJ (1988) Testing for the equality of area under the curve when using destructive measurement techniques. J Pharmacokinet Biopharm 16:303
5. Yeh C (1990) Estimation and significance tests of area under the curve derived from incomplete blood sampling. In: ASA Proceedings of the Biopharmaceutical Section, p 4
6. Nedelman J.R., Jia X (1998) An extension of Satterthwaite?s approximation applied to pharmacokinetics. J Biopharm Stat 8(2):317
7. Hing JP, Woolfrey SG, Wright PMC (2001) Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data. J Pharmacokinet Pharmacodyn 28(5):465
8. Benet LZ (1972) General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. J Pharm Sci 61:536
9. Benet LZ, Galeazzi RL (1979) Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 48:1071
10. Gibaldi M, PerrierD(1982) Pharmacokinetics. Revised and expanded, 2nd edn. Marcel Dekker Inc., New York, NY
11. Jusko WJ (1992) Guidelines for collection and analysis of pharmacokinetic data. In: Evans WE, Schentag JJ, Jusko WJ (eds) Applied pharmacokinetics: principles of therapeutic drug monitoring, 3rd edn. Applied Therapeutics, Spokane, WA
12. Rowland M, Tozer T (2010) Clinical pharmacokinetics and pharmacodynamics: concepts and applications, 4th edn. Lippincott Williams & Wilkins, Maryland
13. Houston JB (1994) Kinetics of disposition of xenobiotics and their metabolites. Drug Metab Drug Interact 6:47
14. Pang KS (1985) A review of metabolic kinetics. J Pharmacokinet Biopharm 13(6):633
15. Watari N, Benet LZ (1989) Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs. J Pharmacokinet Biopharm 17 (1):593
16. Gillespie WR (1991) Noncompartmental versus compartmental modeling in clinical pharmacokinetics. Clin Pharmacokinet 20:253